Rothstein, Brooke. “Topical JAK Inhibitor Ruxolitinib for Vitiligo Treatment”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S110-S111. Accessed January 20, 2025. https://skin.dermsquared.com/skin/article/view/451.